| CVE-2018-14786 | Date: (C)2018-08-24 (M)2023-12-22 |
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
CVSS Score and Metrics +CVSS Score and Metrics -| CVSS V3 Severity: | CVSS V2 Severity: |
| CVSS Score : 9.4 | CVSS Score : 7.5 |
| Exploit Score: 3.9 | Exploit Score: 10.0 |
| Impact Score: 5.5 | Impact Score: 6.4 |
| |
| CVSS V3 Metrics: | CVSS V2 Metrics: |
| Attack Vector: NETWORK | Access Vector: NETWORK |
| Attack Complexity: LOW | Access Complexity: LOW |
| Privileges Required: NONE | Authentication: NONE |
| User Interaction: NONE | Confidentiality: PARTIAL |
| Scope: UNCHANGED | Integrity: PARTIAL |
| Confidentiality: LOW | Availability: PARTIAL |
| Integrity: HIGH | |
| Availability: HIGH | |
| | |
